BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38361511)

  • 1. Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer.
    Wang Y; Yu B; Qu M; Liu F; Wu X
    Exp Ther Med; 2024 Mar; 27(3):109. PubMed ID: 38361511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins.
    Lu H; Wu Z; Wang Y; Zhao D; Zhang B; Hong M
    Phytomedicine; 2022 Sep; 104():154291. PubMed ID: 35839735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5.
    Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X
    J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KLF5‑mediated expression of CARD11 promotes the progression of gastric cancer.
    Li Q; Li S; Li Z; Xu H; Zhang W
    Exp Ther Med; 2023 Sep; 26(3):422. PubMed ID: 37602310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
    Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions and Functions of Krüppel Like Factor 5 and Tumor Necrosis Factor Receptor Superfamily Member 11a in Cervical Cancer Tissues and Cells.
    Chang L; Ma D; Li O; Wang X; Zhang Q; Zhang L; Yan X; Zheng H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Apr; 39(2):196-205. PubMed ID: 28483017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet isoform of phosphofructokinase promotes aerobic glycolysis and the progression of non‑small cell lung cancer.
    Wang F; Li L; Zhang Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-like factor 5 promotes lung tumorigenesis through upregulation of Sox4.
    Li Q; Dong Z; Zhou F; Cai X; Gao Y; Wang LW
    Cell Physiol Biochem; 2014; 33(1):1-10. PubMed ID: 24401325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXC13 promotes cell proliferation, metastasis and glycolysis in breast cancer by regulating DNMT3A.
    Li H; Gao P; Chen H; Zhao J; Zhang X; Li G; Wang L; Qin L
    Exp Ther Med; 2023 Sep; 26(3):439. PubMed ID: 37614427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF5 silence attenuates proliferation and epithelial-mesenchymal transition induction in Hep-2 cells through NF-κB signaling pathway.
    Liu FF; Dong L; Yang X; Li DJ; Shen YY; Liu ZL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3867-3875. PubMed ID: 31115014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
    Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0068481 Affects the Human Pulmonary Artery Smooth Muscle Cells' Progression by miR-361-3p/KLF5 Axis.
    Li HR; Chen GL; Fang XL; Cai XJ; Xu RL; Li DD; Zhang ZW
    Am J Hypertens; 2024 Jan; 37(1):33-45. PubMed ID: 37738301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway.
    Song G; Fang J; Shang C; Li Y; Zhu Y; Xiu Z; Sun L; Jin N; Li X
    Exp Cell Res; 2021 Dec; 409(2):112926. PubMed ID: 34793774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells.
    Hamzeloo-Moghadam M; Aghaei M; Abdolmoham Madi MH; Fallahian F
    J Cancer Res Ther; 2019; 15(5):1105-1108. PubMed ID: 31603118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145-5p Regulates the Proliferation, Migration and Invasion in Cervical Carcinoma by Targeting KLF5.
    Cao H; Pan G; Tang S; Zhong N; Liu H; Zhou H; Peng Q; Zou Y
    Onco Targets Ther; 2020; 13():2369-2376. PubMed ID: 32256087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Britannin induces apoptosis through AKT-FOXO1 pathway in human pancreatic cancer cells.
    Moeinifard M; Hassan ZM; Fallahian F; Hamzeloo-Moghadam M; Taghikhani M
    Biomed Pharmacother; 2017 Oct; 94():1101-1110. PubMed ID: 28821161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.
    Xia W; Bai H; Deng Y; Yang Y
    J Cell Mol Med; 2020 Nov; 24(21):12642-12655. PubMed ID: 32985124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of KLF5/LDH-A feedback loop contributes to Curcumol inhibition of sinusoidal endothelial cell glycolysis and mitigation of liver fibrosis.
    Li Y; Zhou Y; Xia S; Chen L; Yang T; Zhao D; Zhang Z; Shao J; Xu X; Zhang F; Zheng S
    Phytomedicine; 2023 Jun; 114():154759. PubMed ID: 37031640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
    Wang Q; Wu H; Wu Q; Zhong S
    Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.